Thermo Fisher Scientific Finalizes $3.1 Billion Acquisition of Olink, Ushering in a New Era in Proteomics

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, has announced the successful completion of ...

July 11, 2024 | Thursday | News
Certara to Acquire Chemaxon, Expanding Biosimulation Capabilities in Drug Discovery

Certara, Inc.  a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire Chemaxon, a leadi...

July 10, 2024 | Wednesday | News
Certara to Acquire Chemaxon, Expanding Biosimulation Capabilities in Drug Discovery

Certara, Inc.  a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire Chemaxon, a leadi...

July 10, 2024 | Wednesday | News
Myricx Bio Secures £90m Series A Funding Co-Led by Novo Holdings and Abingworth

£90m ($114m) series A co-led by new leading life science investors Novo Holdings and Abingworth Additional new investors British Patient Capital...

July 08, 2024 | Monday | News
Valneva's Single-Dose Chikungunya Vaccine, IXCHIQ®, Receives European Commission Approval

  Valneva SE , a specialty vaccine company, today announced that the European Commission (EC) has granted marketing authorization in Europe for Val...

July 01, 2024 | Monday | News
Bio-Rad Laboratories Introduces Advanced Single-Cell RNA-Seq Kit and Analysis Software

Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, announced the launch of the ddSEQTM Single-Cell 3' RNA-...

June 20, 2024 | Thursday | News
Corning and NIBRT Partner to Advance Biopharmaceutical Manufacturing in Europe

Corning Incorporated announced a collaboration with the National Institute for Bioprocessing Research and Training (NIBRT), one of the world&rs...

June 20, 2024 | Thursday | News
Macomics and IOR Collaborate to Advance Prostate Cancer Research with Novel Macrophage-Targeted Therapies

Laboratory of Prof. Andrea Alimonti at IOR (Institute of Oncology Research, Bellinzona, Switzerland) and Macomics to bring together expertise on myeloi...

June 19, 2024 | Wednesday | News
Alvotech and Advanz Pharma Partner to Commercialize Biosimilar Eylea® Candidates in Europe

  Alvotech  a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz P...

June 18, 2024 | Tuesday | News
Global Cancer Cases Set to Surge to 32 Million Annually by 2050, with Dramatic Increases in Low-Income Countries

Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a pot...

June 11, 2024 | Tuesday | Reports
EnGeneIC Announces Strategic Partnerships to Advance Cancer Therapy in Asia

EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has today announ...

June 07, 2024 | Friday | News
BIO 2024: U.S. Officials Emphasize Vital National Security Partnership with Biotech Industry

At the opening of the 2024 BIO International Convention in San Diego, federal officials underscored the critical role of the biotechnology industry in sa...

June 04, 2024 | Tuesday | News
Bruker Corporation Introduces Innovative neofleX Imaging Profiler for Mass Spectrometry-Based Tissue Analysis

Bruker Corporation announced the launch of a novel, high-performance MALDI-TOF/TOF system, the neofleX Imaging Profiler for mass spectrometry-based ...

June 03, 2024 | Monday | News
Thermo Fisher Scientific Advances Research with New Analytical Instruments and Workflow Capabilities for Precision Medicine

  Thermo Fisher Scientific, a global leader in scientific research solutions, has introduced cutting-edge solutions aimed at enhancing research wor...

June 03, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close